首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Activity of A-56268 compared with that of erythromycin and other oral agents against aerobic and anaerobic bacteria.
【2h】

Activity of A-56268 compared with that of erythromycin and other oral agents against aerobic and anaerobic bacteria.

机译:与红霉素和其他口服药物相比A-56268对需氧和厌氧细菌的活性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A-56268 was compared with erythromycin, roxithromycin (RU 28965), and perorally administered antimicrobial agents. Its in vitro activity was similar to that of erythromycin and slightly greater than that of roxithromycin, with beta-hemolytic streptococci and Streptococcus pneumoniae inhibited by less than 2 micrograms of A-56268 per ml (50% inhibited by 0.06 microgram/ml). Streptococcus pyogenes, S. agalactiae, S. Pneumoniae, and S. faecalis resistant to erythromycin were resistant to A-56268, and 4 micrograms/ml inhibited 90% of Haemophilus influenzae isolates.
机译:将A-56268与红霉素,罗红霉素(RU 28965)和经口服抗菌剂进行比较。它的体外活性类似于红霉素,略高于罗红霉素,β-溶血性链球菌和肺炎链球菌每毫升的A-56268抑制量低于2微克(50%抑制0.06微克/毫升)。化脓性链球菌,无乳链球菌,肺炎链球菌和粪便链球菌对红霉素有抗性,对A-56268有抗性,并且4微克/毫升抑制了90%的流感嗜血杆菌分离株。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号